Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 16.24 CNY -0.12%
Market Cap: 27.1B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Shijiazhuang Yiling Pharmaceutical Co Ltd stock under the Base Case scenario is 25.38 CNY. Compared to the current market price of 16.24 CNY, Shijiazhuang Yiling Pharmaceutical Co Ltd is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
25.38 CNY
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
25
vs Industry
38
Median 3Y
3.5
Median 5Y
3.2
Industry
2.5
Forward
2.6
vs History
1
vs Industry
6
Median 3Y
26.1
Median 5Y
22.6
Industry
21.8
Forward
19.7
vs History
19
vs Industry
29
Median 3Y
17.3
Median 5Y
17.3
Industry
16.1
vs History
vs Industry
28
Median 3Y
17.1
Median 5Y
17.3
Industry
23.8
vs History
66
vs Industry
35
Median 3Y
3.5
Median 5Y
3.1
Industry
2.1
vs History
22
vs Industry
36
Median 3Y
3.6
Median 5Y
3.2
Industry
2.7
Forward
2.6
vs History
7
vs Industry
35
Median 3Y
6.2
Median 5Y
5.3
Industry
5.2
vs History
1
vs Industry
8
Median 3Y
21.3
Median 5Y
18.1
Industry
13.5
Forward
13.4
vs History
1
vs Industry
10
Median 3Y
21.3
Median 5Y
18.1
Industry
16.8
Forward
18.8
vs History
19
vs Industry
31
Median 3Y
17.1
Median 5Y
16.4
Industry
15.2
vs History
vs Industry
24
Median 3Y
15
Median 5Y
15
Industry
19.3
vs History
76
vs Industry
37
Median 3Y
3.1
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
27.2B CNY 3.3 182.7 82.2 82.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
199.5B CHF 3.4 17.3 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.6B GBP 4.1 31.4 168.9 253.1
CH
Novartis AG
SIX:NOVN
171.3B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
CN
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Average P/E: 49.1
182.7
39%
4.7
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.3
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Average EV/EBITDA: 421.8
82.2
50%
1.6
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
168.9
64%
2.6
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Average EV/EBIT: 1 818.3
82.2
11%
7.5
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.1
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top